Effect of edaravone therapy in Korean amyotrophic lateral sclerosis (ALS) patients

Oxidative stress caused by free radicals has been implicated in the pathogenesis of amyotrophic lateral sclerosis (ALS). Edaravone (also known as MCI-186), a free radical scavenger, was approved as an ALS treatment in 2015 in Japan. However, the therapeutic effects of edaravone on patients with ALS...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Jin-Mo, Kim, Sun-Young, Park, Donghwi, Park, Jin-Sung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7223963/
https://www.ncbi.nlm.nih.gov/pubmed/31471712
http://dx.doi.org/10.1007/s10072-019-04055-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7223963/
https://www.ncbi.nlm.nih.gov/pubmed/31471712
http://dx.doi.org/10.1007/s10072-019-04055-3

Ejemplares similares